Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2000, Vol. 5 ›› Issue (2): 187-188.
Previous Articles Next Articles
Received:
2000-02-25
Revised:
2000-04-20
Online:
2000-06-26
Published:
2020-12-01
CLC Number:
1 Hanson P R.My ocardial reperfusion injury:experi-mental e vidence and clinical rele vance.Eur her t J, 1995;1 6(6):734 2 刘凤芝, 李延平, 黄明莉, 等.冬虫夏草醇提取物对大鼠缺血再灌注过程心肌保护作用研究.中国病理生理杂志, 1999;15(3):240 3 Moorman JR, Kir sch GE, Lacerda AE, et a l.An-giotensin Ⅱ modulates cardiacNa + channe ls in neo-natal rat.CireRes, 1989;65:1 804 4 C raw ford KW, Freg EA, Co te TE.Ang io tensin Iire-cept or recognize by DuP 753 regula tes twodistinct guanine nucleo tide-binding protein signaling path-w ay s.M ol pharmacol, 1992;4 1:154 5 Isascson JS, Reid IA.Import ance of endog enous an-g iotensin Ⅱ in the cardiovasoularresponses to sym-pathetic stimulation in conscious rabbits.Circ Res, 1990;66:6 62 6 Baker KM, Singer HA, Fo stal DE.Cardial actions of angiotensin Ⅱ:Role of an intracardiacrenin-an-g iotensin sy stem.J Pharmacol Exp Ther, 1989:2 51: 578 7 郭向阳, 徐守春, 罗爱伦, 等.卡托普利对心肌组织高能磷酸化合物代谢的影响.中华胸心血管外科杂志,1998;14:115 8 Baker KM,Booz GN,Do stal DZ,et al.Cardiacactionsof angio tensin Ⅱ:Role of an intracardioc renin-an-g iotensin sy stem.Annu Rev physiol, 1992;5 4:227 9 郭向阳, 罗爱伦, 徐守春, 等.疏甲丙脯酸对犬在体心脏缺血再灌注后血流动力学的影响.中国医学科学院学报, 1997;19:212 10 章友华, 徐守春.卡托普利对大鼠肥厚心肌受缺血再灌注损伤的保护作用及其机制探讨.中华心血管病杂志, 1996;24:455 11 吴立玲, 齐鹰, 苏静怡, 等.卡托普利对缺血再灌注损伤的保护作用.中华心血管病杂志, 1994;22(5):379 12 Baumarten C R, Linz W, Kunkel G, et al.Ramiprilatincreases br adykinin ou tflow from isola ted hearts of rat.Br J Pharmacol, 1993;108:293 13 Parr att JR.Cardioprotection by any io tensin conver tingenzymeinhitors the exper imental evidence.Cardiovase Res,1994;28:1 83 14 张敏, 潘敬远, 朱小南, 等.疏甲丙脯酸降低缺血再灌注心率失常的发生率.生理学报, 1995;47(6):559 15 濮家伉, 贺广远, 王红兰, 等.卡托普利对大鼠离体心脏缺血再灌注损伤的保护作用.南京铁道医学院学报, 1997;16(3):166 16 Liu YH, Yang XP, Sharov VG, et al.Paracrine sy s-tems in the cardioprotenctive effect of angio tensin-convertingenzymeinhibitor s on my ocardial ischemia/reper fusion injury in rats.Hyper teusion, 1996:2 7(1): 7 17 罗爱伦, 郭向阳, 徐守春, 等.卡托普利对犬缺血现灌注损伤心脏保护作用实验研究.中华心血管病杂志, 1998:26(3):226 18 Koemer JE, ander son BA, Dage RC, et al.Pro tection a g ainst postischemic my ocardial dy sfunction in anes-thetized rabbits with scavengers of oxyg enderived f reeradicals.J Cardeovasc Pharma col, 1991;17:185 19 夏正远, 顾家珍, 林芳华, 等.体外循环下心肌缺血再灌注后血清过氧化脂质及前列腺素的变化.临床麻醉医学杂志, 1997;13(2):82 20 Lui FM, Xu SC.Effect of captoril cardioplegia on ren-inang iotensinsy stem,prostag landins, freeradicals and eletroly tes in the isolated hypothermic ischemic and reperfusion rabbitheart s.C hin med J, 1993;106:903 21 Hartman JC.Therole of bradykinin and nitric oxide in the cardioprotective action of ACEI.Ann ThoracSurg, 1995;60:7 89 22 黄忠耀, 朱洪生, 张有荣, 等.卡托普利心脏停搏液对缺血再灌注心肌NOS 活性和NO 产生的影响.中华胸心外科杂志, 1999;15(3):182 23 Kingma JH, Van Gilst WH,Peels CH, et al.Acute in-ter vention with captopril during thrombolysis in pa-tients with first anterior my ocardial inf arction.Eurp Hearts J,1994;15:898 24 Sharpe N, Smith H,Murphy J, et al.Early prevention of left ventriculardy sfunction after myocardial in-farction with angiotensin-cover ting-e nzymeinhibition. Lancet, 1991;3 37(8746):872 25 Ikeda U,M aeda Y,Kaw ahara Y, et al.Angio tensin I I augments cytokine-stimulated nitricoxide synthesis inrat cardia c myocytes.Circulation,1995;92:2 683 |
[1] | CHEN Xi, LI Yongjun. Effects of Chinese patent medicine for activating blood circulation on cardiac repair after myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 680-688. |
[2] | XU Jianfei, LIN Li. Research progress in pharmacological and non-pharmacological treatments of hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 433-441. |
[3] | YUAN Zhen, CHEN Bilian. Review of bleeding events in clinical studies of clopidogrel [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 341-349. |
[4] | XING Kai, GONG Jinyu, LUO Jianquan. Advances on pharmacogenomics of diuretics-related adverse reactions [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 204-212. |
[5] | DANG Xiangji, ZHOU Lin, WANG Yixuan, ZENG Lu. Individualized antithrombotic therapy on one patient with chronic renal insufficiency [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 477-480. |
[6] | PU Chun, TAO Qingsong, ZHU Xiang, QIN Mingming, WU Qiwen, FENG Gang. Value of three cardiac markers in the early diagnosis of acute myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 82-86. |
[7] | JIANG Peng-li, WU Jing, SUN He. Association of cognitive decline, diabetes mellitus and cancer with statins use: gaining insight through the FDA pharmacovigilance database [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1132-1138. |
[8] | WANG Pan, XIE Shan-shan, GUO Jian-jun, BU Hai-zhi, CHEN Xi-jing. Research overview in absorption, distribution, metabolism and excretion of dihydropyridine calcium antagonists [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 937-943. |
[9] | WANG Zhen-shan, LI Ling, DENG Xiao-lan, LI Hui, YU Min, YAN Jin, CHEN Ben-mei, YANG Guo-ping, OU-YANG Dong-sheng. LC-MS determination of terazosin in human plasma and application [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(5): 530-534. |
[10] | ZHANG Hong-xia, WU Yong-jie, GAO Ming-tang. Protective effects of DDPH on myocardial ischemia reperfusion injury in isolated rat hearts [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 160-165. |
[11] | WANG Zhan-qing, WANG Jin-ping, XU Jing-feng. Isosorbide dinitrate induces late preconditioning against myocardial infarction in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(12): 1385-1388. |
[12] | ZHU Shen-yin, ZHOU Yuan-da, DU Guan-hua. Research progress of xanthine oxidoreductase in biological functions and its inhibitor development [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1081-1086. |
[13] | XUE Hao, GAO Min, LIU Guo-shu, WANG Hai. Effect of iptakalim hydrochloride on extracellular matrix of kidney in spontaneously hypertensive rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1122-1128. |
[14] | WANG Zhan-qing, YING Xiang-yu, XU Jing-feng. Advances in preclinical studies on combination therapy of myocardial ischemia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 847-850. |
[15] | YU Shuang, YU Li-mei, YUAN Mu, YU Hong, WU Qin, SHI Jin-shan. Effect of naftopidil'ramification-BWYJ on benign prostatic hyperplasia in mice and rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 873-877. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||